Sutro Biopharma Inc
STRO·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$15.70
Today
-0.1%
YTD
+38.0%
About
Sutro Biopharma, Inc. is a clinical-stage biopharmaceutical company working to create protein therapeutics for cancer and autoimmune disorders. Founded in 2003, the company has headquarters in South San Francisco, California and operates within the US. Sutro Biopharma stock is listed on the NASDAQ GM stock exchange with the ticker STRO. Get the latest STRO stock news by adding it to your eToro watchlist.
Price chart
Closing price history for STRO (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-1.81
P/S (TTM)3.90
P/B (TTM)-7.36
Market cap$492.64M
Cap tierSmall-cap
Industry avg P/E-43.35
Profitability
Gross margin93.27%
EBIT margin-87.44%
Net margin-264.99%
ROE-1810.01%
ROA-54.53%
Earnings & Revenue
Revenue (TTM)$99.61M
Revenue growth (1Y)+49.9%
EPS (TTM)-$16.45
Free cash flow$-152.14M
Total debt$242.74M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.51
Employees137
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.